![](/wp-content/uploads/2018/10/c3Wye8cORnmEfiopH9Qs.png)
$599
Lilly Increases Diabetes Manufacturing Investment in 2017
Lilly has announced intentions to invest $850M in its US operations in 2017 including $85M to expand the Trulicity device assembly operations. Additionally, Lilly announced the dedication of a $140M insulin cartridge facility.